- Home
- Publications
- Publication Search
- Publication Details
Title
The Evolution of Neurofilament Light Chain in Multiple Sclerosis
Authors
Keywords
-
Journal
Frontiers in Neuroscience
Volume 15, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-04-06
DOI
10.3389/fnins.2021.642384
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Neurofilament light chain in a phase 2 clinical trial of ibudilast in progressive multiple sclerosis
- (2021) Robert J Fox et al. Multiple Sclerosis Journal
- Serum neurofilament light levels in normal aging and their association with morphologic brain changes
- (2020) Michael Khalil et al. Nature Communications
- The potential of neurofilaments analysis using dry-blood and plasma spots
- (2020) Vittoria Lombardi et al. Scientific Reports
- Confounding effect of blood volume and body mass index on blood neurofilament light chain levels
- (2020) Ali Manouchehrinia et al. Annals of Clinical and Translational Neurology
- Plasma tau, neurofilament light chain and amyloid-β levels and risk of dementia; a population-based cohort study
- (2020) Frank de Wolf et al. BRAIN
- Neurofilaments in progressive multiple sclerosis: a systematic review
- (2020) Thomas Williams et al. JOURNAL OF NEUROLOGY
- Plasma neurofilament light levels are associated with the risk of disability in multiple sclerosis
- (2020) Ali Manouchehrinia et al. NEUROLOGY
- Relevance of biomarkers across different neurodegenerative diseases
- (2020) Alexander J. Ehrenberg et al. Alzheimers Research & Therapy
- Serum biomarkers in myelin oligodendrocyte glycoprotein antibody–associated disease
- (2020) Hyunjin Kim et al. Neurology-Neuroimmunology & Neuroinflammation
- The role of chemokines and chemokine receptors in multiple sclerosis
- (2020) Li-Yuan Cui et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Serum neurofilament light as a biomarker in progressive multiple sclerosis
- (2020) Raju Kapoor et al. NEUROLOGY
- Serum neurofilament light chain predicts long term clinical outcomes in multiple sclerosis
- (2020) Simon Thebault et al. Scientific Reports
- A Score Based on NfL and Glial Markers May Differentiate Between Relapsing–Remitting and Progressive MS Course
- (2020) André Huss et al. Frontiers in Neurology
- Clinical implication of serum biomarkers and patient age in inflammatory demyelinating diseases
- (2020) Eun‐Jae Lee et al. Annals of Clinical and Translational Neurology
- Clinical implications of serum neurofilament in newly diagnosed MS patients: A longitudinal multicentre cohort study
- (2020) Stefan Bittner et al. EBioMedicine
- Long-term prognostic value of longitudinal measurements of blood neurofilament levels
- (2020) Dieter A. Häring et al. Neurology-Neuroimmunology & Neuroinflammation
- Neurofilament light chain, a biomarker for polyneuropathy in systemic amyloidosis
- (2020) Jelger Louwsma et al. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
- Serum neurofilament-light concentration and real-world outcome in MS
- (2020) Valerie Anderson et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Neurofilaments in motor neuron disorders: towards promising diagnostic and prognostic biomarkers
- (2020) Elisabetta Zucchi et al. Molecular Neurodegeneration
- CSF neurofilament light chain testing as an aid to determine treatment strategies in MS
- (2020) Saúl Reyes et al. Neurology-Neuroimmunology & Neuroinflammation
- Serum neurofilament light chain
- (2020) Orhan Aktas et al. Neurology-Neuroimmunology & Neuroinflammation
- Prognostic value of serum neurofilaments in patients with clinically isolated syndromes
- (2019) Gloria Dalla Costa et al. NEUROLOGY
- Blood neurofilament light chain as a biomarker of MS disease activity and treatment response
- (2019) Jens Kuhle et al. NEUROLOGY
- Longitudinal analysis of serum neurofilament light chain: A potential therapeutic monitoring biomarker for multiple sclerosis
- (2019) Jae-Won Hyun et al. Multiple Sclerosis Journal
- Neuromyelitis optica spectrum disorders
- (2019) Kazuo Fujihara CURRENT OPINION IN NEUROLOGY
- Serum neurofilaments increase at progressive multifocal leukoencephalopathy onset in natalizumab-treated multiple sclerosis patients
- (2019) Gloria Dalla Costa et al. ANNALS OF NEUROLOGY
- Cerebrospinal fluid neurofilament light chain tracks cognitive impairment in multiple sclerosis
- (2019) Lorenzo Gaetani et al. JOURNAL OF NEUROLOGY
- Neurofilament light chain serum levels reflect disease severity in MOG-Ab associated disorders
- (2019) Sara Mariotto et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Cerebrospinal fluid neurofilament light chain in multiple sclerosis and its subtypes: a meta-analysis of case–control studies
- (2019) Sarah-Jane Martin et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Neurofilament light chain as a biomarker in neurological disorders
- (2019) Lorenzo Gaetani et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Increased cerebrospinal fluid neurofilament light chain in central nervous system inflammatory demyelinating disease
- (2019) Lijun Peng et al. Multiple Sclerosis and Related Disorders
- Clinical and MRI correlates of CSF neurofilament light chain levels in relapsing and progressive MS
- (2019) Alfredo Damasceno et al. Multiple Sclerosis and Related Disorders
- Neurofilament Light Chain as a Biomarker in Multiple Sclerosis
- (2019) Kristin N. Varhaug et al. Frontiers in Neurology
- Blood neurofilament light as a potential endpoint in Phase 2 studies in MS
- (2019) Maria Pia Sormani et al. Annals of Clinical and Translational Neurology
- Plasma Neurofilaments correlate with Disability in Progressive Multiple Sclerosis patients
- (2019) Diana Ferraro et al. ACTA NEUROLOGICA SCANDINAVICA
- Neurofilament light chain in the assessment of patients with multiple sclerosis
- (2019) Renan Barros DOMINGUES et al. ARQUIVOS DE NEURO-PSIQUIATRIA
- Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology
- (2019) Claire Bridel et al. JAMA Neurology
- Cerebrospinal fluid neurofilament light chain predicts disease activity after the first demyelinating event suggestive of multiple sclerosis
- (2019) Lorenzo Gaetani et al. Multiple Sclerosis and Related Disorders
- The Cerebrospinal Fluid in Multiple Sclerosis
- (2019) Florian Deisenhammer et al. Frontiers in Immunology
- Serum GFAP and neurofilament light as biomarkers of disease activity and disability in NMOSD
- (2019) Mitsuru Watanabe et al. NEUROLOGY
- Establishment of neurofilament light chain Simoa assay in cerebrospinal fluid and blood
- (2019) Robert Hendricks et al. Bioanalysis
- Association Between Serum Neurofilament Light Chain Levels and Long-term Disease Course Among Patients With Multiple Sclerosis Followed up for 12 Years
- (2019) Ester Cantó et al. JAMA Neurology
- Serum Neurofilament Light Chain Levels in Patients With Presymptomatic Multiple Sclerosis
- (2019) Kjetil Bjornevik et al. JAMA Neurology
- Combined Cerebrospinal Fluid Neurofilament Light Chain Protein and Chitinase-3 Like-1 Levels in Defining Disease Course and Prognosis in Multiple Sclerosis
- (2019) Sara Gil-Perotin et al. Frontiers in Neurology
- Dimethyl fumarate decreases neurofilament light chain in CSF and blood of treatment naïve relapsing MS patients
- (2019) Tobias Sejbaek et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Neurofilament light levels are associated with long-term outcomes in multiple sclerosis
- (2019) Jens Kuhle et al. Multiple Sclerosis Journal
- History of fatigue in multiple sclerosis is associated with grey matter atrophy
- (2019) Miklos Palotai et al. Scientific Reports
- Fatigue scores correlate with other self-assessment data, but not with clinical and biomarker parameters, in CIS and RRMS
- (2019) Irene Håkansson et al. Multiple Sclerosis and Related Disorders
- Molecular biomarkers in multiple sclerosis
- (2019) Tjalf Ziemssen et al. Journal of Neuroinflammation
- Predictive Models of Cognitive Fatigue in Multiple Sclerosis
- (2018) Jason A Berard et al. ARCHIVES OF CLINICAL NEUROPSYCHOLOGY
- Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis
- (2018) Christian Barro et al. BRAIN
- Neurofilament light chain and oligoclonal bands are prognostic biomarkers in radiologically isolated syndrome
- (2018) Clara Matute-Blanch et al. BRAIN
- Neurofilament levels, disease activity and brain volume during follow-up in multiple sclerosis
- (2018) Irene Håkansson et al. Journal of Neuroinflammation
- Serum and CSF neurofilament light chain levels in patients with acquired peripheral neuropathies
- (2018) Sara Mariotto et al. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
- Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension
- (2018) Raju Kapoor et al. LANCET NEUROLOGY
- Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
- (2018) Alan J Thompson et al. LANCET NEUROLOGY
- High neurofilament levels are associated with clinically definite multiple sclerosis in children and adults with clinically isolated syndrome
- (2018) Roos M van der Vuurst de Vries et al. Multiple Sclerosis Journal
- CSF inflammatory biomarkers responsive to treatment in progressive multiple sclerosis capture residual inflammation associated with axonal damage
- (2018) Jeppe Romme Christensen et al. Multiple Sclerosis Journal
- Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis
- (2018) Nelly Siller et al. Multiple Sclerosis Journal
- Multiple sclerosis: CSF markers predict progression from radiologically isolated syndrome
- (2018) Ian Fyfe Nature Reviews Neurology
- Plasma neurofilament light chain concentration in the inherited peripheral neuropathies
- (2018) Åsa Sandelius et al. NEUROLOGY
- Multiple Sclerosis
- (2018) Daniel S. Reich et al. NEW ENGLAND JOURNAL OF MEDICINE
- Searching for neurodegeneration in multiple sclerosis at clinical onset: Diagnostic value of biomarkers
- (2018) Lenka Novakova et al. PLoS One
- Osteopontin (OPN) as a CSF and blood biomarker for multiple sclerosis: A systematic review and meta-analysis
- (2018) Elmira Agah et al. PLoS One
- A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation
- (2018) Lorenzo Gaetani et al. Alzheimers Research & Therapy
- High neurofilament levels are associated with clinically definite multiple sclerosis in children and adults with clinically isolated syndrome
- (2018) Roos M van der Vuurst de Vries et al. Multiple Sclerosis Journal
- CSF inflammatory biomarkers responsive to treatment in progressive multiple sclerosis capture residual inflammation associated with axonal damage
- (2018) Jeppe Romme Christensen et al. Multiple Sclerosis Journal
- Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis
- (2018) Nelly Siller et al. Multiple Sclerosis Journal
- Neurofilaments and 10-year follow-up in multiple sclerosis
- (2018) Alok Bhan et al. Multiple Sclerosis Journal
- Neurofilaments as biomarkers in neurological disorders
- (2018) Michael Khalil et al. Nature Reviews Neurology
- Multiple sclerosis - a review
- (2018) R. Dobson et al. EUROPEAN JOURNAL OF NEUROLOGY
- Unraveling treatment response in multiple sclerosis
- (2018) Claudio Gasperini et al. NEUROLOGY
- Neurofilament light chain serum levels correlate with 10‐year MRI outcomes in multiple sclerosis
- (2018) Tanuja Chitnis et al. Annals of Clinical and Translational Neurology
- Neurofilament light chain in cerebrospinal fluid and prediction of disease activity in clinically isolated syndrome and relapsing-remitting multiple sclerosis
- (2017) I. Håkansson et al. EUROPEAN JOURNAL OF NEUROLOGY
- The role of blood and CSF biomarkers in the evaluation of new treatments against multiple sclerosis
- (2017) Jan Lycke et al. Expert Review of Clinical Immunology
- Science is 1% inspiration and 99% biomarkers
- (2017) Nicolas Dubuisson et al. Multiple Sclerosis Journal
- Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod
- (2017) Fredrik Piehl et al. Multiple Sclerosis Journal
- Monitoring disease activity in multiple sclerosis using serum neurofilament light protein
- (2017) Lenka Novakova et al. NEUROLOGY
- Science is 1% inspiration and 99% biomarkers
- (2017) Nicolas Dubuisson et al. Multiple Sclerosis Journal
- Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod
- (2017) Fredrik Piehl et al. Multiple Sclerosis Journal
- Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa
- (2016) Jens Kuhle et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Elevated CSF neurofilament proteins predict brain atrophy: A 15-year follow-up study
- (2016) Axel Petzold et al. Multiple Sclerosis Journal
- Cerebrospinal fluid biomarkers of inflammation and degeneration as measures of fingolimod efficacy in multiple sclerosis
- (2016) Lenka Novakova et al. Multiple Sclerosis Journal
- Personalised medicine for multiple sclerosis care
- (2016) Arie Gafson et al. Multiple Sclerosis Journal
- Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severity
- (2016) Jens Kuhle et al. Multiple Sclerosis Journal
- Reduced inflammation in relapsing-remitting multiple sclerosis after therapy switch to rituximab
- (2016) Pierre de Flon et al. NEUROLOGY
- Neurofilament light chain level is a weak risk factor for the development of MS
- (2016) Georgina Arrambide et al. NEUROLOGY
- Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases
- (2016) Mehtap Bacioglu et al. NEURON
- Multicenter validation of CSF neurofilaments as diagnostic biomarkers for ALS
- (2016) Patrick Oeckl et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Elevated CSF neurofilament proteins predict brain atrophy: A 15-year follow-up study
- (2016) Axel Petzold et al. Multiple Sclerosis Journal
- Cerebrospinal fluid biomarkers of inflammation and degeneration as measures of fingolimod efficacy in multiple sclerosis
- (2016) Lenka Novakova et al. Multiple Sclerosis Journal
- Personalised medicine for multiple sclerosis care
- (2016) Arie Gafson et al. Multiple Sclerosis Journal
- Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severity
- (2016) Jens Kuhle et al. Multiple Sclerosis Journal
- Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study
- (2016) Magnus Gisslén et al. EBioMedicine
- Neurofilaments as Biomarkers for Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis
- (2016) Zhouwei Xu et al. PLoS One
- No prognostic value of routine cerebrospinal fluid biomarkers in a population-based cohort of 407 multiple sclerosis patients
- (2015) Madlyne Becker et al. BMC Neurology
- Defining high, medium and low impact prognostic factors for developing multiple sclerosis
- (2015) Mar Tintore et al. BRAIN
- Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome
- (2015) Giulio Disanto et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- The prognostic value of CSF neurofilaments in multiple sclerosis at 15-year follow-up
- (2015) A. Petzold JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- The only certain measure of the effectiveness of multiple sclerosis therapy is cerebrospinal neurofilament level—NO
- (2015) Georgina Arrambide et al. Multiple Sclerosis Journal
- What drives MRI-measured cortical atrophy in multiple sclerosis?
- (2015) V Popescu et al. Multiple Sclerosis Journal
- Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis
- (2015) M Alba Mañé Martínez et al. Multiple Sclerosis Journal
- Chitinase 3-like proteins as diagnostic and prognostic biomarkers of multiple sclerosis
- (2015) G Hinsinger et al. Multiple Sclerosis Journal
- Fingolimod and CSF neurofilament light chain levels in relapsing-remitting multiple sclerosis
- (2015) J. Kuhle et al. NEUROLOGY
- The only certain measure of the effectiveness of multiple sclerosis therapy is cerebrospinal neurofilament level—NO
- (2015) Georgina Arrambide et al. Multiple Sclerosis Journal
- Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis
- (2015) M Alba Mañé Martínez et al. Multiple Sclerosis Journal
- Chitinase 3-like proteins as diagnostic and prognostic biomarkers of multiple sclerosis
- (2015) G Hinsinger et al. Multiple Sclerosis Journal
- What drives MRI-measured cortical atrophy in multiple sclerosis?
- (2015) V Popescu et al. Multiple Sclerosis Journal
- Elevated neurofilament light chain (NFL) mRNA levels in prediabetic peripheral neuropathy
- (2014) Asuman Celikbilek et al. MOLECULAR BIOLOGY REPORTS
- Cerebrospinal fluid neurofilament tracks fMRI correlates of attention at the first attack of multiple sclerosis
- (2014) C Tortorella et al. Multiple Sclerosis Journal
- Neurofilament light antibodies in serum reflect response to natalizumab treatment in multiple sclerosis
- (2014) Sandra Amor et al. Multiple Sclerosis Journal
- Natalizumab in progressive MS: Results of an open-label, phase 2A, proof-of-concept trial
- (2014) J. Romme Christensen et al. NEUROLOGY
- Regional but Not Global Brain Damage Contributes to Fatigue in Multiple Sclerosis
- (2014) Maria A. Rocca et al. RADIOLOGY
- Axonal degeneration in multiple sclerosis: can we predict and prevent permanent disability?
- (2014) Jae Young Lee et al. Acta Neuropathologica Communications
- The improvement of cognitive functions is associated with a decrease of plasma Osteopontin levels in Natalizumab treated relapsing multiple sclerosis
- (2013) Pietro Iaffaldano et al. BRAIN BEHAVIOR AND IMMUNITY
- Clinical, MRI, and CSF Markers of Disability Progression in Multiple Sclerosis
- (2013) Alberto Gajofatto et al. DISEASE MARKERS
- Serum and cerebrospinal fluid light neurofilaments and antibodies against them in clinically isolated syndrome and multiple sclerosis
- (2013) Lenka Fialová et al. JOURNAL OF NEUROIMMUNOLOGY
- Plasma osteopontin levels are associated with disease activity in the patients with multiple sclerosis and neuromyelitis optica
- (2013) Yuko Shimizu et al. JOURNAL OF NEUROIMMUNOLOGY
- Immunosuppressive therapy reduces axonal damage in progressive multiple sclerosis
- (2013) Markus Axelsson et al. Multiple Sclerosis Journal
- Biomarker Report from the Phase II Lamotrigine Trial in Secondary Progressive MS – Neurofilament as a Surrogate of Disease Progression
- (2013) Sharmilee Gnanapavan et al. PLoS One
- Increased Neurofilament Light Chain Blood Levels in Neurodegenerative Neurological Diseases
- (2013) Johanna Gaiottino et al. PLoS One
- Neurofilaments at a glance
- (2012) A. Yuan et al. JOURNAL OF CELL SCIENCE
- CSF inflammation and axonal damage are increased and correlate in progressive multiple sclerosis
- (2012) Jeppe Romme Christensen et al. Multiple Sclerosis Journal
- Osteopontin: A key link between immunity, inflammation and the central nervous system
- (2012) Amanda Brown Translational Neuroscience
- Chitinase 3-like 1 plasma levels are increased in patients with progressive forms of multiple sclerosis
- (2011) E Cantó et al. Multiple Sclerosis Journal
- Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab
- (2010) Martin Gunnarsson et al. ANNALS OF NEUROLOGY
- Oligoclonal bands and MRI in clinically isolated syndromes: predicting conversion time to multiple sclerosis
- (2010) Rojas Juan Ignacio et al. JOURNAL OF NEUROLOGY
- The Chemokine CXCL13 Is a Prognostic Marker in Clinically Isolated Syndrome (CIS)
- (2010) Johannes Brettschneider et al. PLoS One
- Multiple sclerosis – candidate mechanisms underlying CNS atrophy
- (2010) Volker Siffrin et al. TRENDS IN NEUROSCIENCES
- Greater loss of axons in primary progressive multiple sclerosis plaques compared to secondary progressive disease
- (2009) E. C. Tallantyre et al. BRAIN
- CSF oligoclonal band status informs prognosis in multiple sclerosis: a case control study of 100 patients
- (2008) F G Joseph et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Magnetic resonance imaging measures of brain and spinal cord atrophy correlate with clinical impairment in secondary progressive multiple sclerosis
- (2008) J Furby et al. Multiple Sclerosis Journal
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started